Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release

A dysfibrinogenemia (fibrinogen Bethesda) was detected in a 9 yr old male of Mexican-English extraction who had a lifelong history of mild bleeding diathesis. The prothrombin and partial thromboplastin times were moderately prolonged; the thrombin and Reptilase times were markedly prolonged. The pla...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 1971-09, Vol.50 (9), p.1819-1830
Main Authors: Gralnick, H R, Givelber, H M, Shainoff, J R, Finlayson, J S
Format: Article
Language:English
Subjects:
Adult
Blood Protein Disorders - blood
Blood Protein Disorders - congenital
Blood Protein Disorders - genetics
Chromatography, DEAE-Cellulose
England
Ethnic Groups
Fibrin - analysis
Fibrinogen - analysis
Genes, Dominant
Humans
Immunoelectrophoresis
Male
Mexico
Middle Aged
Molecular Biology
Peptides - analysis
Prothrombin Time
Thrombin
Trichloroacetic Acid
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A dysfibrinogenemia (fibrinogen Bethesda) was detected in a 9 yr old male of Mexican-English extraction who had a lifelong history of mild bleeding diathesis. The prothrombin and partial thromboplastin times were moderately prolonged; the thrombin and Reptilase times were markedly prolonged. The plasma fibrinogen level was normal by conventional methods but was markedly reduced by the Clauss method. Results of all other tests for clotting factors, fibrinolysis, antithrombin levels, clot stabilization, and fibrin(ogen) degradation products were normal. The patient's plasma and fibrinogen inhibited the clotting of normal plasma or fibrinogen by thrombin. Family studies revealed that the propositus' mother and two siblings exhibited these abnormalities to a lesser degree and indicated an autosomal dominant inheritance. Fibrinogen Bethesda was similar to normal fibrinogen in the following respects: metabolic turnover time (measured in the propositus' mother); immunodiffusion, ultracentrifugal, electrophoretic (on cellulose acetate or polyacrylamide gel), and chromatographic (on DEAE-cellulose) characteristics; sialic acid content; and aggregation of fibrin monomers. By contrast, fibrinogen Bethesda gave an abnormal immunoelectrophoretic pattern especially when whole plasma (as opposed to purified fibrinogen) was examined, and it showed a pronounced decrease in the rate of fibrinopeptide release by thrombin. This decrease, which was shown to involve both fibrinopeptides A and B, distinguishes fibrinogen Bethesda from previously reported dysfibrinogenemias.
ISSN:0021-9738
DOI:10.1172/JCI106673